Matthew E. Falagas

Matthew E. Falagas is an Adjunct Associate Professor of Medicine at Tufts University School of Medicine and Director of the First Department of Internal Medicine at Hygeia Hospital in Athens, Greece. He is affiliated with multiple institutions, including the Alfa Institute of Biomedical Sciences (AIBS) and the European University Cyprus, where he contributes to biomedical research and education.

• Academic Appointments: Adjunct Research Professor at European University Cyprus School of Medicine, Adjunct Associate Professor at Tufts University School of Medicine
• Key Organizations: European Society of Clinical Microbiology and Infectious Diseases (ESCMID), ECDC-CDC task force, Henry Dunant Hospital Center

Dr. Falagas specializes in infectious diseases and internal medicine, with a focus on antimicrobial resistance, pharmacotherapy, and hospital infections. His research spans clinical trials, systematic reviews, and the development of international definitions for multidrug-resistant bacteria.

His recent publications address critical topics in infectious disease management, including antimicrobial efficacy against resistant Gram-negative bacilli, infusion strategies for β-lactams in sepsis, and pharmacokinetic adjustments for bodyweight. These works reflect his expertise in antibiotic stewardship and clinical microbiology.

Dr. Falagas has received numerous scientific accolades, including:

• ESCMID Fellow (2017)
• Maxwell Finland Young Investigator Award (1997)
• Edward Kass Award for Clinical Excellence (1994)
• Repeated recognition as a highly cited researcher in Internal Medicine and Microbiology (2023, 2022, 2018)

He has organized national seminars on antibiotic use and infectious disease trends and served as a principal investigator for studies on fosfomycin, polymyxin B, and novel antimicrobials. His editorial roles include positions on Expert Review of Anti-Infective Therapy and Medscape Infectious Diseases advisory boards.